Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing's syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775422PMC
http://dx.doi.org/10.3390/ijms23020673DOI Listing

Publication Analysis

Top Keywords

mild hypercortisolism
24
cortisol secretion
12
bone fragility
8
hypercortisolism
7
mild
5
pathophysiology mild
4
hypercortisolism bench
4
bench bedside
4
bedside mild
4
hypercortisolism defined
4

Similar Publications

Article Synopsis
  • - Individuals with Cushing's disease (CD) often face ongoing mood and cognitive issues even after achieving long-term biochemical remission, with about 30% showing mild impairments and high rates of anxiety and depression.
  • - The study compared neuropsychological functioning between CD patients in remission and those with nonfunctioning adenomas (NFA) around 4.9 years post-surgery, finding no significant differences but highlighting persistent mental health challenges in both groups.
  • - The findings emphasize the need for regular neuropsychological assessments and tailored support for patients with CD and NFA to address and manage lasting cognitive and psychiatric issues.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the impact of smoking on the health profile and surgical outcomes of patients with primary aldosteronism (PA).
  • In a retrospective analysis of 881 PA patients from 36 Spanish hospitals, smokers exhibited higher rates of left ventricular hypertrophy (LVH) and larger adrenal tumors compared to non-smokers, although their blood pressure and potassium levels were similar at diagnosis.
  • The results indicated that while smoking is linked to a greater prevalence of LVH and mild autonomous cortisol secretion (MACS), it does not significantly influence hypertension cure rates after surgery for PA.
View Article and Find Full Text PDF

Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study.

Eur J Endocrinol

November 2024

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, 97080 Würzburg, Germany.

Objective: Cushing's syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. Subtype-specific differences and possible reversibility after biochemical cure are not well investigated.

Design: Prospective cohort study evaluating the CV status in different forms of endogenous cortisol excess.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!